drugset / Trial / NCT00093509

MRI Sarcoma Non Invasive Thermometry

NCT00093509

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Hyperthermia therapy kills tumor cells by heating them to several degrees above body temperature. Using MRI to measure heat may help to determine the effectiveness of hyperthermia therapy. Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy, such as ifosfamide and doxorubicin, work in different ways to stop tumor cells from dividing so they stop growing or die. Combining hyperthermia with radiation therapy and chemotherapy before surgery may kill more tumor cells and shrink the tumor so that it can be removed. PURPOSE: This phase I/II trial is studying the side effects of hyperthermia when given together with radiation therapy and optional chemotherapy and to see how well they work in treating patients who are undergoing surgery for soft tissue sarcoma of the limbs.

Timeline

Start
1999-11
Primary completion
2007-07
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Background 2-MERCAPTOETHANESULFONIC ACID Small molecule 2500 mg/m2 Intravenous
Background Doxorubicin Other / unclassified 75 mg/m2 Intravenous
Background Ifosfamide Small molecule 2000 mg/m2 Intravenous

Indications